The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with ...

A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial ...

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International ...

Self-measured SBP and DBP were more reduced by amlodipine than by candesartan cilexetil after 12 weeks of treatment. The mean difference between the treatments showed self-measured DBP to be ...

OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1) blood pressure (BP) reduction and control, total cardiovascular risk ...

Cardiovascular disease remains the leading cause of death in patients with diabetes. Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk factors leads to ...

Teva Pharmaceuticals announced that Fitch Ratings has upgraded its corporate credit rating from BB to BB+, maintaining a stable outlook. This upgrade reflects Teva's efforts to reduce debt ...

‘Impractical and even sadistic’: Why Gayton McKenzie thinks ministers must fly business class Oscar Pistorius makes waves after return to sport at Ironman in Durban DEVELOPING | Trump says Musk has ...

Teva Pharmaceutical Industries Ltd. announced that it is launching tender offers to purchase up to $2 billion in cash for various series of notes issued by its finance subsidiaries and guaranteed ...